The company is burning cash at an unsustainable rate with a $19.5M stockholders' deficit and deeply negative operating cash flow. The 'beating management projections' sequential growth narrative masks a 77% YoY revenue collapse. Monitor the Health Lives Here app launch and Datavault transaction closing for any revenue inflection; risk of Nasdaq delisting persists given reverse split and penny-stock situation.
Price Chart
Executive Summary
DataMeds AI (MEDS) reported Q2 2026 revenue of $1.78 million, down 77% YoY from $7.79 million, and a net loss of $18.36 million compared to a $6.67 million loss in the prior-year quarter. The deep revenue decline, massive operating loss driven by $8.88 million in debt extinguishment charges, and negative stockholders' equity of $19.5 million signal severe financial distress despite a sequential revenue increase and recent $6.5 million funding.
Key Financial Metrics
Key Facts
- Revenue fell to $1.78M from $7.79M YoY, a 77% decline
- Net loss widened to $18.36M from $6.67M YoY
- EPS loss was $7.13 per share vs $5.40 YoY
- Debt extinguishment loss of $8.88M booked in Q2
- Stockholders' deficit was $19.5M; total liabilities exceeded assets by $19.5M
- Raised $6.5M in new funding; restructured $14.5M of debt
- 1:50 reverse split completed in May 2026
- Holders of ~49% of shares entered 90-day lock-up agreements
- Health Lives Here app launch with NFL Alumni Health expected September 2026
- Cash and cash equivalents improved to $2.46M from $0.04M at year-end 2025
Financial Impact
Revenue declined ~77% YoY to $1.78M; net loss of $18.36M; accumulated deficit of $137.1M
Risk Factors
- Nasdaq delisting risk — stock trading at low levels post 1:50 reverse split
- Going-concern risk: $19.5M stockholders' deficit and massive operating losses
- Dilution from convertible notes ($12.1M) and debt obligations ($7.1M current)
- Revenue base shrunk 77% YoY — no sign of stabilization in core pharmacy business
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-038891 |
| Document: form8-k.htm | 0001493152-26-038891 |
| Document: 0001493152-26-038891-index-headers.html | 0001493152-26-038891 |
| Document: 0001493152-26-038891-index.html | 0001493152-26-038891 |
| Document: 0001493152-26-038891.txt | 0001493152-26-038891 |
| 8-K Data (Synthetic) | 0001493152-26-038891 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.15 | awaiting T+20 | — | $2.19 (−1.86%) |
Oct 20, 2026 6d ago | 8-K | $2.75 | awaiting T+20 | — | $2.19 (−20.36%) |
Oct 16, 2026 10d ago | 8-K | $2.67 | awaiting T+20 | — | $2.19 (−17.98%) |
Oct 13, 2026 13d ago | 8-K | $2.85 | awaiting T+20 | — | $2.19 (−23.16%) |
Sep 17, 2026 5w ago | 8-K | $3.76 $2.63 | ▼ −30.05% | ▼ −30.26% | $2.19 (−41.76%) |
Sep 16, 2026 5w ago | 8-K | $4.64 $2.85 | ▼ −38.58% | ▼ −39.78% | $2.19 (−52.80%) |
Aug 18, 2026 9w ago | 8-K | $1.38 $6.07 | ▼ −339.86% | ▼ −341.60% | $2.19 (−58.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers